Thus, in light of the promising potential of the anti-PD-1 or anti-PD-L1 immunotherapy in cancer treatments (32), it is of vital importance to gain an in-depth and comprehensive understanding of the regulatory mechanisms of PD-1 and PD-L1 in carcinogenesis, progression, and metastasis. Here, CD274 is linked to cancer.